Test Price
2,800 AED✅ Home Collection Available
EGR2 Gene CMT4E Next‑Generation Sequencing Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity via ISO‑certified processing and full‑gene Next‑Generation Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post‑test consultation for result interpretation included.
- Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The EGR2 gene CMT4E NGS test decodes the entire coding sequence of the EGR2 gene to identify pathogenic variants causing Charcot‑Marie‑Tooth disease type 4E, a severe early‑onset demyelinating neuropathy. The test uses Next‑Generation Sequencing (NGS) to confirm the molecular diagnosis and guide genetic counselling and treatment planning with certified accuracy.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Full‑gene coverage, >99% sensitivity for point mutations & small indels | Limited to selected exons; risk of missing deep intronic or novel variants |
| Methodology | Next‑Generation Sequencing (NGS) with confirmatory Sanger validation | Sanger sequencing of individual amplicons |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Clinical Utility | Comprehensive genotype–phenotype correlation, carrier testing & family screening | Basic mutation detection, less informative for complex rearrangements |
Physician Insight & Safety Protocols
“A diagnosis of Charcot‑Marie‑Tooth disease can be deeply unsettling for patients and families. This test confirms the molecular basis of CMT4E, allowing us to tailor rehabilitation strategies and discuss inheritance risks with empathy. Please remember that genetic results must be integrated with a complete neurological exam—never self‑interpret.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Do Not Discontinue Prescribed Medication
🔴 Do not discontinue or alter any prescribed medication without consulting your physician. Genetic test results are adjunctive and do not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Acute febrile illness or active systemic infection – reschedule post recovery.
- Recent blood transfusion or bone marrow transplant (within 4 weeks) – invalidates DNA source.
- Co‑existing severe respiratory or cardiac compromise – immediate physician assessment required.
- Seek emergency care if: sudden worsening of limb weakness, swallowing difficulty, or respiratory distress develops before or after testing.
Patient FAQ & Clinical Guidance
1. How is the EGR2 gene test used to diagnose Charcot‑Marie‑Tooth disease?
This Next‑Generation Sequencing test reads the entire EGR2 gene to identify disease‑causing mutations responsible for Charcot‑Marie‑Tooth type 4E, providing molecular confirmation of the clinical diagnosis.
2. Do I need to fast before sample collection?
No fasting is required. A simple blood draw, extracted DNA, or one drop of blood on an FTA card is sufficient for the test.
3. How long do results take and does the price include genetic counselling?
Results are reported within 3–4 weeks and the package includes a post‑test genetic counselling session to explain your personal results.
UAE Regulatory & Data Privacy Adherence
This test is performed in strict compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. All genetic data is encrypted, anonymised, and processed within secure UAE‑based servers.
Clinical & Logistical Metadata
| Test Name | EGR2 Gene CMT4E Next‑Generation Sequencing |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood, extracted DNA, or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) with confirmatory Sanger validation |
| ICD‑10‑CM Code | G60.0 |
| LOINC Code | 94409-2 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians